Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dublin, OH
SEC filing record 1 source field available
Fiscal year end
31 December
NAVIDEA BIOPHARMACEUTICALS, INC. has filed 1,465 SEC EDGAR filings since 07 Feb 1995

SEC filing history

Showing 576-600 of 949 matching filings.

Per page
25
Current page
24
8-K File 001-35076

FORM 8-K

Filing date
17 Dec 2014
Reporting date
15 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Dec 2014
Reporting date
10 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Dec 2014
Reporting date
08 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-35076

CT ORDER filing

Filing date
09 Dec 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Nov 2014
Reporting date
13 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

CURRENT REPORT

Filing date
14 Nov 2014
Reporting date
11 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

CURRENT REPORT

Filing date
13 Nov 2014
Reporting date
12 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Nov 2014
Reporting date
10 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Nov 2014
Reporting date
10 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Nov 2014
Reporting date
10 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Nov 2014
Reporting date
10 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Nov 2014
Reporting date
10 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Nov 2014
Reporting date
10 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

CURRENT REPORT

Filing date
06 Nov 2014
Reporting date
06 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
16 Oct 2014
Reporting date
15 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
15 Oct 2014
Reporting date
13 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
15 Oct 2014
Reporting date
13 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Oct 2014
Reporting date
07 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
01 Oct 2014
Reporting date
26 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
24 Sep 2014
Reporting date
18 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-183317

POST-EFFECTIVE AMENDMENT NO. 1

Filing date
16 Sep 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-198716

REGISTRATION STATEMENT

Filing date
12 Sep 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
10 Sep 2014
Reporting date
04 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Sep 2014
Reporting date
02 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .